FDG-PET may predict the effectiveness of hyperbaric oxygen therapy in a patient with bisphosphonate-related osteonecrosis of the jaw: report of a case. | Canada Hyperbarics Skip to main content
Clinical Study Odontology 2015

FDG-PET may predict the effectiveness of hyperbaric oxygen therapy in a patient with bisphosphonate-related osteonecrosis of the jaw: report of a case.

Fatema CN, Sato J, Yamazaki Y, Hata H, Hattori N, Shiga T, et al. — Odontology, 2015

View Original on PubMed PMID 23907202
Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported on an 80-year-old woman with bisphosphonate-related osteonecrosis of the jaw (BRONJ) who received hyperbaric oxygen therapy and other treatments, observing changes with FDG-PET.

What They Found

After 20 sessions of hyperbaric oxygen therapy, the patient's clinical symptoms resolved. Concurrently, the SUVmax of FDG-PET decreased significantly from 4.5 to 2.5, while other imaging modalities showed no notable changes. Following minor surgery and additional HBO therapy, the patient's recovery was excellent.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

The primary limitation of this study is that it is a single case report, meaning its findings cannot be generalized to a broader patient population without further research.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Uncategorised
Source Pubmed
PubMed ID 23907202
Year Published 2015
Journal Odontology
MeSH Terms Aged, 80 and over; Bisphosphonate-Associated Osteonecrosis of the Jaw; Female; Fluorodeoxyglucose F18; Humans; Hyperbaric Oxygenation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals

Cite This Study

Share

Related Research

J Int Med Res | 2004 RCT

Effectiveness of hyperbaric oxygen therapy in the treatment of complex regional pain syndrome

Kiralp MZ, Yildiz S, Vural D, et al.
Undersea Hyperb Med | 2013 Clinical Study

The efficacy of hyperbaric oxygen therapy in the management of chronic fatigue syndrome

Akarsu S, Tekin L, Ay H, et al.
Int J Med Sci | 2024 Retrospective Study

The effectiveness of hyperbaric oxygen treatment in patients with complex regional pain syndrome: a retrospective case series

Hajek M, Hadanny A, Engel-Yeger B, et al.
BMJ Open | 2024 RCT

Protocol for a multicentric, double-blind, randomised controlled trial of HBOT versus sham for vaso-occlusive crisis in sickle cell disease (HBOT-SCD study)

Stirnemann J, Serratrice J, Mann T, et al.
Undersea Hyperb Med | 2024 RCT

Outcomes after pancreaticoduodenectomy with or without preoperative hyperbaric oxygen therapy

Jacoby H, Camporesi EM, Ross SB, et al.
See all Uncategorised research
View on PubMed Back to Research Library

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology